Filing summary
Entity mismatch: The request identifies TERAWULF INC., but the supplied filing is IKONICS CORPORATION’s Form 10-Q for the quarter ended September 30, 2013. The summary below reflects the filing text, not TeraWulf. Financial statements are unaudited.
Business context and reporting period
IKONICS reported results for the three and nine months ended September 30, 2013, compared with the corresponding 2012 periods. Its businesses include Domestic, Export, IKONICS Imaging, Digital Texturing (DTX), and Micro-Machining. Beginning in the third quarter, DTX and Micro-Machining were reported as separate segments.
Financial performance and position
- Third-quarter revenue: $4.217 million, down 0.3% from $4.231 million. Gross profit was $1.642 million (38.9% margin), versus $1.753 million (41.4%). Operating income was $162,000 versus $338,000; net income was $116,000 versus $228,000. Diluted EPS was $0.06 versus $0.11.
- Nine-month revenue: $12.894 million, up 0.8% from $12.788 million. Gross profit was $4.990 million (38.7% margin), versus $5.062 million (39.6%). Operating income was $389,000 versus $607,000; net income was $322,000 versus $409,000. Diluted EPS was $0.16 versus $0.21.
- Cash flow: Nine-month operating cash flow was $1.151 million, compared with $567,000 in 2012. Investing activities used $1.003 million, including $586,000 of property and equipment purchases and net purchases of short-term investments. Financing provided $63,000 from stock-option exercises. Cash increased $212,000 to $1.179 million.
- Liquidity and debt: At September 30, cash and cash equivalents were $1.179 million and short-term investments were $1.815 million; current assets totaled $7.779 million and current liabilities $1.091 million. No borrowings were outstanding on the $1.25 million credit line, available through May 31, 2015 if not renewed. Total liabilities were $1.522 million, including $431,000 of deferred tax liabilities; the filing reports no outstanding line-of-credit debt.
- Other metrics: Foreign sales were approximately 33% of nine-month revenue. Research and development expense was $476,000, or 3.7% of sales, versus $470,000, also 3.7%, in 2012.
Changes versus prior comparable periods
- Revenue was nearly flat in the third quarter and modestly higher for the nine-month period, but operating and net income declined in both comparisons.
- Lower gross margins reflected Micro-Machining production costs and lower volume against a largely fixed cost base, as well as reduced higher-margin IKONICS Imaging sales. Higher SG&A also weighed on operating results.
- Domestic and Export sales increased in the third quarter, partly offset by declines in Micro-Machining and IKONICS Imaging. For the first nine months, Domestic and Export growth was partly offset by a 32% Micro-Machining sales decline and lower IKONICS Imaging and DTX sales.
- Operating cash flow improved, supported in part by lower receivables and inventory. Capital spending rose to $586,000 from $372,000 in the 2012 period.
Outlook, commentary, and risks
- Management expected a 28% effective tax rate for the remainder of 2013; the nine-month rate was 18.5%, partly reflecting tax benefits recognized in the first quarter. The third-quarter rate was 28.7%.
- Management planned to continue R&D investment, product development, technology alliances, and capital spending, including additional manufacturing upgrades. It believed available resources and operating cash flow would fund expected operations and expenditures.
- Management described progress in Micro-Machining and DTX, including aerospace feasibility work and customer collaboration. It cautioned that defense-budget sequestration or delays in commercial aircraft programs could affect some aerospace sales; adoption of new products, competition, market conditions, and raw-material costs could also affect results.
- Other disclosed uncertainties include tax-law changes, capital expenditure needs, international market conditions, and the success of product development and expansion initiatives. The company reported no off-balance-sheet arrangements and no legal proceedings in this filing.
- Management stated that disclosure controls were effective and that no material change in internal control over financial reporting was identified during the period.
Important facts for investors to verify
- Confirm the intended issuer: the supplied filing is for IKONICS CORPORATION, not TERAWULF INC.
- Review the causes and sustainability of lower gross margins and declining operating income, particularly in Micro-Machining and IKONICS Imaging.
- Assess whether Micro-Machining and DTX investments and aerospace-related opportunities can generate sufficient revenue to offset their operating costs.
- Verify the expected tax rate and treatment of tax benefits when evaluating subsequent-period earnings.
- Compare planned capital expenditures and working-capital requirements with operating cash generation and available liquidity.